MDFirst Research — Lancaster, South Carolina

MDFirst Research is a clinical research site located in Lancaster, South Carolina, United States 29720.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

MDFirst Research has participated in 2 clinical trials.

Therapeutic areas: Type 2 Diabetes, Chronic Obstructive Pulmonary Disease.

Sponsors: Eli Lilly and Company, Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lancaster

Browse all research sites in South Carolina · View every site in Lancaster

• Carolina Blood and Cancer Care Associates PA-Lancaster
• Carolina Heart Specialists
• Carolina Blood and Cancer Care Associates, PA
• Research Site
• Lancaster Radiation Therapy Center
• GSK Investigational Site
• MD First Research
• Medical Facility
• MDFirst
• Investigator Site 11-119
• Carolina Blood and Cancer Care Associate

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MDFirst Research?

MDFirst Research has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MDFirst Research conducted?

MDFirst Research has 2 clinical trials on record. Their work covers Type 2 Diabetes, Chronic Obstructive Pulmonary Disease.

Is MDFirst Research accredited by Crixeo Clinical Trials?

MDFirst Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MDFirst Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.